Last updated on

Endocrine Pathology
Research Hotspot & Journal Scope - Tumor


Endocrine Pathology - DOI: 10.1007/s12022-019-9568-5
An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors

Omalkhaire M. Alshaikh · Sylvia L. Asa · Ozgur Mete · Shereen Ezzat ·

Medicine
PDF
Endocrine Pathology - DOI: 10.1007/s12022-019-9573-8
PITX2 Expression in Non-functional Pituitary Neuroendocrine Tumor with Cavernous Sinus Invasion

Ryota Tamura · Kentaro Ohara · Yukina Morimoto · Kenzo Kosugi · Yumiko Oishi · Mizuto Sato · Kazunari Yoshida · Masahiro Toda ·

Biology Medicine
PDF
Endocrine Pathology - DOI: 10.1007/s12022-018-9563-2
The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas

Rovshan Hasanov · Berna İmge Aydoğan · Saba Kiremitçi · Esra Erden · Sevim Güllü ·

Medicine
PDF
Endocrine Pathology - DOI: 10.1007/s12022-018-9562-3
Plurihormonal Pituitary Tumor of Pit-1 and SF-1 Lineages, with Synchronous Collision Corticotroph Tumor: a Possible Stem Cell Phenomenon

Karen M Tordjman · Yona Greenman · Zvi Ram · Dov Hershkovitz · Orna Aizenstein · Ofra Ariel · Sylvia L Asa ·

Medicine
PDF
Endocrine Pathology - DOI: 10.1007/s12022-019-09593-2
Molecular Heterogeneity of Papillary Thyroid Cancer: Comparison of Primary Tumors and Synchronous Metastases in Regional Lymph Nodes by Mass Spectrometry Imaging

Marta Gawin · Agata Kurczyk · Ewa Stobiecka · Katarzyna Frątczak · Joanna Polańska · Monika Pietrowska · Piotr Widłak ·

Biology Medicine
PDF

Data Synthesis: Abemaciclib is an oral, potent, small molecule inhibitor of CDK4 and CDK6 activity, which blocks retinoblastoma tumor suppressor protein phosphorylation and thereby prevents progression through the cell cycle.

Abemaciclib: The Newest CDK4/6 Inhibitor for the Treatment of Breast Cancer [10.1177/1060028018795146]


It is frequently dysregulated in cancer, making Aurora A inhibition a very attractive antitumor target.

Covalent Aurora A regulation by the metabolic integrator coenzyme A [10.1016/j.redox.2019.101318]


Whether prophylactic or therapeutic, these vaccines aim to enhance the T cell-mediated anti-tumor immune response that is orchestrated by dendritic cells.

Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity [10.3389/fimmu.2019.00824]


Further, to add to the complex genomic landscape of AML, it is now well known that heterogeneity is found not only between patients (intertumor heterogeneity) but also within individual leukemias (intratumor heterogeneity) [3].

Unexpected variation in leukemia stem cell frequency and genetic heterogeneity in two murine leukemia models initiated by AML1/ETO9a and CALM/AF10 [10.1038/s41375-019-0657-8]


Thalamic tumors are an uncommon occurrence in children.

An Unusual Masquerader of Progressive Myoclonic Epilepsy [10.1007/s12098-019-03056-6]


Highly Related Keywords from Tumor

Research Hotspot

Endocrine Pathology

Research Hotspot
Endocrine Pathology Related Journals

Popular Journals